The National Cancer Authority has begun distributing a new shipment of specialized cancer medications to oncology centers and hospitals across Libya to help meet the treatment needs of patients.
The shipment includes Zoladex (3.6 mg and 10.8 mg), Velcade (3.5 mg), and Zytiga (500 mg).
The medications are being supplied to the National Institute for Cancer Treatment in Sabratha and Misrata, as well as Tripoli Central Hospital, Tripoli University Hospital, and Tripoli Medical Center.
